The Australian Therapeutic Goods Administration says the benefits of the AstraZeneca vaccine far outweigh the risks after a woman died from a blood clot in the brain in the state of New South Wales (NSW).
The TGA says the 52-year-old who died was among four new clotting cases linked to the vaccine.
